Sources | Names Used |
---|---|
CTRPv2 | navitoclax:PLX-4032 (1:1 mol/mol) |
PharmacoGx | navitoclax:PLX-4032 (1:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | NYNRIN | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
mRNA | SPHK2 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
mRNA | ABCE1 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
mRNA | SERGEF | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
mRNA | SPDYE2B | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
mRNA | AGTRAP | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
mRNA | DEFA5 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
mRNA | SAGE1 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.001 |
mRNA | ONECUT2 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
mRNA | BLZF1 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |